Introducing OpenBioLLM-Llama3-70B & 8B: Saama’s AI Research Lab Released the Most Openly Available Medical-Domain LLMs to Date
Related Posts
![](https://cdn.sanity.io/images/0vv8moc6/act/a8e281cddd6801b1587201493f95b659d1760091-6240x4160.jpg?fit=crop&auto=format)
Rinvoq Found Superior to Dupixent in Key Endpoints of Open-Label Trial Treating Atopic Dermatitis
Image credit: InfiniteStudio | stock.adobe.com Findings from the Phase IIIb/IV LEVEL UP (NCT05601882) trial demonstrated the superiority of AbbVie’s Rinvoq (upadacitinib)…
![](https://cdn.sanity.io/images/0vv8moc6/act/1b0e1c900e8a973b7263fe0dd3dd782ad765f628-3072x2048.jpg?fit=crop&auto=format)
Comparing End Points Between Non-Small Cell Lung Cancer Clinical Trials, Observational Studies
Image Credit: © iDoPixBox – stock.adobe.com A study recently published in JAMA Network Open compared response- and progression-based end points…
![](https://cdn.sanity.io/images/0vv8moc6/act/ba299741486dd80afa7298820b8aedae8e10f99d-3600x2400.jpg?fit=crop&auto=format)
FDA Lifts Partial Clinical Hold on Phase II Trial of Novel Tumor Infiltrating Lymphocyte Cell Therapy for NSCLC
Image credit: Crystal light | stock.adobe.com The FDA has removed a partial clinical hold on a Phase II trial evaluating…